ANGO Valuation

AngioDynamics Inc

Add to Watchlist

Advanced Chart

9.290

+0.100(+1.090%)

Overview
Forecast
Valuation

ANGO Relative Valuation

ANGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ANGO is overvalued; if below, it's undervalued.

Historical Valuation

AngioDynamics Inc (ANGO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.25 is considered Undervalued compared with the five-year average of 1.78. The fair price of AngioDynamics Inc (ANGO) is between 12.38 to 22.56 according to relative valuation methord. Compared to the current price of 9.29 USD , AngioDynamics Inc is Undervalued By 24.99%.

Relative Value

Fair Zone

12.38-22.56

Current Price：9.29

24.99%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.05

P/B

Median3y

1.35

Median5y

1.50

-7.55

FCF Yield

Median3y

-4.83

Median5y

-3.32

Competitors Valuation Multiple

The average P/S ratio for ANGO's competitors is 4.00, providing a benchmark for relative valuation. AngioDynamics Inc Corp (ANGO) exhibits a P/S ratio of 1.25, which is -68.82% above the industry average. Given its robust revenue growth of -4.23%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap